Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 0.00 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Immune Therapeutics Inc (PK) | IMUN | OTCMarkets | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.093 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.093 |
| Trades | Shares Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0.00 | - | 0.06675 - 0.90 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| - | 0 | US$ 0.093 | USD |
Immune Therapeutics Inc (PK) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 7.53M | 83.60M | - | 0 | -1.65M | -0.02 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Immune Therapeutics (PK) News
| Date | Time | Source | News Article |
|---|---|---|---|
| 4/01/2024 | 07:05 | Edgar (US Regulatory) | Form NT 10-K - Notification of inability to timely file Form.. |
| 11/14/2023 | 15:22 | Edgar (US Regulatory) | Form 8-K - Current report |
| 11/14/2023 | 10:43 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 11/02/2023 | 08:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 10/24/2023 | 08:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 9/14/2023 | 08:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 9/13/2023 | 16:16 | Edgar (US Regulatory) | Form 8-K - Current report |
| 8/18/2023 | 05:02 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 8/14/2023 | 09:03 | Edgar (US Regulatory) | Form NT 10-Q - Notification of inability to timely file Form.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical IMUN Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Year | 0.60 | 0.90 | 0.06675 | 0.3409556 | 19,805 | -0.507 | -84.50% |
| 3 Years | 0.016 | 7.99 | 0.012 | 0.2482718 | 18,109 | 0.077 | 481.25% |
| 5 Years | 0.007 | 7.99 | 0.0037 | 0.0208723 | 887,910 | 0.086 | 1,228.57% |
Immune Therapeutics (PK) Description
| Immune Therapeutics, Inc. is a biotechnology company developing and seeking to commercialize patented therapies in emerging nations that combat chronic, life-threatening diseases by stimulating or rebalancing the immune system. Our technology platform is based on two interrelated cytokine drug therapies-Low-Dose Naltrexone (LDN) and Methionine Enkephalin (MENK)-which work by triggering opioid receptors on immune cells to activate various cells of the immune system. |
